港股健倍苗苗（02161）今日盘中大涨5.78%，引发市场关注。截至发稿时，该股报价为2.84港元，成交额达400.42万港元。
健倍苗苗近期发布的财报显示，公司业绩表现亮眼。截至2025年3月31日的财年，集团收益达7.82亿港元，同比增长20.65%；公司权益持有人应占溢利为1.97亿港元，同比大幅增长51.2%。每股盈利为24.08港仙，公司拟派末期股息每股11.5港仙。业绩增长主要得益于集团旗舰品牌何济公、保济丸及飞鹰活络油的优异表现，以及浓缩中药颗粒业务的稳定贡献。
此外，健倍苗苗还宣布了一项重要的收购计划，拟斥资3800万港元收购健福堂中医集团全部股权。这一战略性收购旨在把握传统中药和预防性健康解决方案需求增长的机遇。通过此次收购，健倍苗苗将能够利用目标集团广泛的诊所网络，扩大其浓缩中药颗粒的分销渠道，并进一步释放其品牌中药产品组合的增长潜力。市场普遍认为，这一举措将有助于公司长期发展，从而推动股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.